(+)-artemisinic acid decreases expression EXP 6480464 [artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA, artemisic acid results in decreased expression of CEBPA mRNA CTD PMID:23063590 (+)-artemisinic acid multiple interactions EXP 6480464 [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol CTD PMID:23063590 (+)-pilocarpine multiple interactions ISO RGD:2326 6480464 [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] CTD PMID:32494933 (-)-cotinine multiple interactions ISO RGD:2326 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein CTD PMID:29617909 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:10325 6480464 epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein] CTD PMID:20438794 (S)-nicotine increases expression ISO RGD:10325 6480464 Nicotine results in increased expression of CEBPA mRNA CTD PMID:31622651 (S)-nicotine affects expression ISO RGD:2326 6480464 Nicotine affects the expression of CEBPA mRNA CTD PMID:31972234 (S)-nicotine multiple interactions ISO RGD:2326 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein CTD PMID:29617909 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions ISO RGD:2326 6480464 2 more ... CTD PMID:19414516 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose multiple interactions ISO RGD:10325 6480464 beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA], beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA protein] CTD PMID:30721698 1,2-dimethylhydrazine multiple interactions ISO RGD:10325 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CEBPA mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:10325 6480464 1, 2-Dimethylhydrazine results in increased expression of CEBPA mRNA CTD PMID:22206623 1-nitropyrene multiple interactions EXP 6480464 [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA], CEBPA protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein] CTD PMID:29078374 1-nitropyrene decreases expression EXP 6480464 1-nitropyrene results in decreased expression of CEBPA mRNA CTD PMID:29078374 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:10325 6480464 15-deoxy-delta12, 14-prostaglandin J2 results in increased expression of CEBPA mRNA CTD PMID:12021203 17alpha-ethynylestradiol decreases activity ISO RGD:2326 6480464 Ethinyl Estradiol results in decreased activity of CEBPA protein CTD PMID:12507762 17beta-estradiol affects expression ISO RGD:10325 6480464 Estradiol affects the expression of CEBPA mRNA CTD PMID:15598610 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CEBPA mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:2326 6480464 Estradiol results in decreased expression of CEBPA mRNA CTD PMID:26164745 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CEBPA mRNA CTD PMID:20106945 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of CEBPA protein CTD PMID:18801408 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:10325 6480464 Dihydrotestosterone results in decreased expression of CEBPA mRNA, Dihydrotestosterone results in decreased expression of CEBPA protein CTD PMID:12960001 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:10325 6480464 2 more ... CTD PMID:24559133 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10325 6480464 Tetrachlorodibenzodioxin affects the expression of CEBPA mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA CTD PMID:28011154 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10325 6480464 Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2326 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA CTD PMID:18796159 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2326 6480464 Tetrachlorodibenzodioxin affects the expression of CEBPA mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10325 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein] more ... CTD PMID:12758056 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2326 6480464 herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]], Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter] CTD PMID:11133817 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10325 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA, Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein CTD PMID:12758056 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:10325 6480464 2 more ... CTD PMID:30903904 2-acetamidofluorene decreases expression ISO RGD:2326 6480464 2-Acetylaminofluorene results in decreased expression of CEBPA protein CTD PMID:20188851 , PMID:21785164 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:10325 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein more ... CTD PMID:22107987 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression ISO RGD:10325 6480464 glucosamine 6-phosphate results in decreased expression of CEBPA protein CTD PMID:19427183 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:10325 6480464 tetrabromobisphenol A results in increased expression of CEBPA mRNA CTD PMID:25863188 , PMID:30496566 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10325 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CEBPA mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine affects methylation ISO RGD:10325 6480464 N-Methyl-3, 4-methylenedioxyamphetamine affects the methylation of CEBPA promoter CTD PMID:26251327 3,5,6-trichloro-2-pyridinol multiple interactions ISO RGD:10325 6480464 3 more ... CTD PMID:32017950 3,5,6-trichloropyridine-2-one multiple interactions ISO RGD:10325 6480464 3 more ... CTD PMID:32017950 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10325 6480464 +-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... CTD PMID:11101056 more ... 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of CEBPA mRNA more ... CTD PMID:23152186 more ... 3-methyladenine multiple interactions EXP 6480464 [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA] CTD PMID:29078374 3-methylcholanthrene multiple interactions ISO RGD:10325 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CEBPA mRNA CTD PMID:23519560 3-phenylprop-2-enal decreases expression ISO RGD:10325 6480464 cinnamic aldehyde results in decreased expression of CEBPA mRNA CTD PMID:21401097 3H-1,2-dithiole-3-thione increases expression ISO RGD:2326 6480464 1, 2-dithiol-3-thione results in increased expression of CEBPA mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis4-hydroxyphenylsulfone results in increased expression of CEBPA mRNA CTD PMID:27003841 4,4'-sulfonyldiphenol increases expression ISO RGD:10325 6480464 bis4-hydroxyphenylsulfone results in increased expression of CEBPA mRNA CTD PMID:30951980 , PMID:30959087 4,4'-sulfonyldiphenol multiple interactions ISO RGD:10325 6480464 [bis4-hydroxyphenylsulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA, [bis4-hydroxyphenylsulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] affects the expression of CEBPA protein CTD PMID:27273607 , PMID:32220626 4-hydroxynon-2-enal increases expression ISO RGD:10325 6480464 4-hydroxy-2-nonenal results in increased expression of CEBPA mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide decreases expression ISO RGD:10325 6480464 Fenretinide results in decreased expression of CEBPA mRNA CTD PMID:16467112 4-tert-Octylphenol decreases expression ISO RGD:2326 6480464 4-tert-octylphenol results in decreased expression of CEBPA mRNA CTD PMID:26164745 5-aza-2'-deoxycytidine affects methylation EXP 6480464 Decitabine affects the methylation of CEBPA promoter CTD PMID:17510391 5-aza-2'-deoxycytidine decreases methylation EXP 6480464 Decitabine results in decreased methylation of CEBPA promoter CTD PMID:19194470 5-azacytidine decreases methylation EXP 6480464 Azacitidine results in decreased methylation of CEBPA promoter CTD PMID:19194470 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of CEBPA mRNA CTD PMID:27590069 6-propyl-2-thiouracil increases expression ISO RGD:2326 6480464 Propylthiouracil results in increased expression of CEBPA mRNA CTD PMID:22504374 acrylamide multiple interactions ISO RGD:10325 6480464 Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA] more ... CTD PMID:30409764 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of CEBPA protein CTD PMID:20106945 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CEBPA mRNA CTD PMID:27153756 , PMID:32234424 AICA ribonucleotide decreases expression ISO RGD:10325 6480464 AICA ribonucleotide results in decreased expression of CEBPA protein CTD PMID:27103584 AICA ribonucleotide multiple interactions ISO RGD:10325 6480464 AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein] CTD PMID:27103584 alcohol decreases expression EXP 6480464 Alcohols results in decreased expression of CEBPA protein CTD PMID:24025710 aldehydo-D-glucosamine 6-phosphate decreases expression ISO RGD:10325 6480464 glucosamine 6-phosphate results in decreased expression of CEBPA protein CTD PMID:19427183 aldehydo-D-glucose multiple interactions EXP 6480464 CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 all-trans-retinoic acid multiple interactions EXP 6480464 PTK2 protein inhibits the reaction [Tretinoin promotes the reaction [CEBPA protein binds to RB1 protein]] more ... CTD PMID:16226872 more ... all-trans-retinoic acid increases activity EXP 6480464 Tretinoin results in increased activity of CEBPA protein CTD PMID:16226872 all-trans-retinoic acid multiple interactions ISO RGD:10325 6480464 Tretinoin inhibits the reaction [CEBPA protein binds to RETN promoter] CTD PMID:15047602 ammonium chloride affects expression ISO RGD:2326 6480464 Ammonium Chloride affects the expression of CEBPA mRNA CTD PMID:16483693 andrographolide multiple interactions ISO RGD:10325 6480464 andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA], andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] CTD PMID:27475717 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 Aroclor 1254 increases expression ISO RGD:2326 6480464 Chlorodiphenyl 54% Chlorine results in increased expression of CEBPA mRNA CTD PMID:11163329 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of CEBPA mRNA, Arsenic results in decreased expression of CEBPA protein CTD PMID:23108036 arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA, Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein] CTD PMID:23108036 , PMID:32525701 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of CEBPA mRNA, Arsenic results in decreased expression of CEBPA protein CTD PMID:23108036 arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA, Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein] CTD PMID:23108036 , PMID:32525701 arsenite(3-) increases expression ISO RGD:10325 6480464 arsenite results in increased expression of CEBPA mRNA CTD PMID:15868481 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CEBPA mRNA CTD PMID:20458559 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CEBPA mRNA, Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:19662097 , PMID:21257625 arsenous acid decreases expression ISO RGD:10325 6480464 Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:15916724 avobenzone decreases expression EXP 6480464 avobenzone results in decreased expression of CEBPA mRNA CTD PMID:31016361 baicalein decreases expression ISO RGD:10325 6480464 baicalein results in decreased expression of CEBPA protein CTD PMID:24560969 benzamides increases expression ISO RGD:10325 6480464 Benzamides results in increased expression of CEBPA mRNA CTD PMID:28242381 benzo[a]pyrene decreases expression ISO RGD:10325 6480464 Benzoapyrene results in decreased expression of CEBPA mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of CEBPA exon CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of CEBPA mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:10325 6480464 Benzoapyrene results in increased expression of CEBPA mRNA CTD PMID:15034205 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of CEBPA mRNA CTD PMID:21714911 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:19150397 benzofurans decreases expression ISO RGD:10325 6480464 Benzofurans results in decreased expression of CEBPA mRNA, Benzofurans results in decreased expression of CEBPA protein CTD PMID:20863820 Benzyl parahydroxybenzoate increases expression ISO RGD:10325 6480464 benzylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 , PMID:27659731 berberine multiple interactions ISO RGD:10325 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA] more ... CTD PMID:20564506 berberine decreases expression EXP 6480464 Berberine results in decreased expression of CEBPA mRNA CTD PMID:26478571 beta-carotene decreases expression ISO RGD:10325 6480464 beta Carotene results in decreased expression of CEBPA mRNA CTD PMID:21569430 beta-D-glucosamine 6-sulfate decreases expression ISO RGD:10325 6480464 glucosamine 6-O-sulfate results in decreased expression of CEBPA mRNA, glucosamine 6-O-sulfate results in decreased expression of CEBPA protein CTD PMID:19520133 beta-naphthoflavone decreases expression ISO RGD:2326 6480464 beta-Naphthoflavone results in decreased expression of CEBPA mRNA, beta-Naphthoflavone results in decreased expression of CEBPA protein CTD PMID:19389873 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10325 6480464 Diethylhexyl Phthalate results in decreased expression of CEBPA mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CEBPA mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:2326 6480464 bisphenol A results in increased expression of CEBPA mRNA CTD PMID:20019905 , PMID:30816183 bisphenol A decreases expression EXP 6480464 bisphenol A analog results in decreased expression of CEBPA mRNA, bisphenol A results in decreased expression of CEBPA mRNA CTD PMID:32387340 bisphenol A increases methylation ISO RGD:2326 6480464 bisphenol A results in increased methylation of CEBPA gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:2326 6480464 bisphenol A results in decreased expression of CEBPA mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CEBPA mRNA CTD PMID:24418828 , PMID:25143472 bisphenol A decreases expression ISO RGD:10325 6480464 bisphenol A results in decreased expression of CEBPA mRNA, bisphenol A results in decreased expression of CEBPA protein CTD PMID:26146954 , PMID:30133442 bisphenol A increases expression ISO RGD:10325 6480464 bisphenol A results in increased expression of CEBPA more ... CTD PMID:26942597 more ... bisphenol A multiple interactions ISO RGD:10325 6480464 [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of CEBPA protein more ... CTD PMID:26820058 more ... Bisphenol A diglycidyl ether multiple interactions ISO RGD:2326 6480464 2, 2-bis4-glycidyloxyphenylpropane inhibits the reaction [TRIB3 protein affects the expression of CEBPA protein] CTD PMID:21190014 Bisphenol A diglycidyl ether multiple interactions ISO RGD:10325 6480464 2, 2-bis4-glycidyloxyphenylpropane inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] CTD PMID:22956630 Bisphenol B decreases expression EXP 6480464 bisphenol B results in decreased expression of CEBPA mRNA CTD PMID:32387340 bisphenol F increases expression ISO RGD:10325 6480464 bisphenol F results in increased expression of CEBPA mRNA CTD PMID:30951980 boric acid multiple interactions ISO RGD:10325 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA] more ... CTD PMID:28285642 bortezomib multiple interactions EXP 6480464 Bortezomib inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] CTD PMID:19662097 Butylbenzyl phthalate multiple interactions ISO RGD:10325 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CEBPA mRNA more ... CTD PMID:26820058 , PMID:28595985 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 Butylparaben increases expression ISO RGD:10325 6480464 butylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 more ... Butylparaben multiple interactions ISO RGD:10325 6480464 2 more ... CTD PMID:22956630 more ... C60 fullerene increases expression ISO RGD:2326 6480464 fullerene C60 results in increased expression of CEBPA mRNA CTD PMID:19167457 cadmium atom decreases expression ISO RGD:2326 6480464 Cadmium results in decreased expression of CEBPA mRNA CTD PMID:17327700 cadmium atom multiple interactions ISO RGD:10325 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA CTD PMID:29939372 cadmium atom decreases expression ISO RGD:10325 6480464 Cadmium results in decreased expression of CEBPA protein CTD PMID:21848503 cadmium dichloride decreases expression ISO RGD:2326 6480464 Cadmium Chloride results in decreased expression of CEBPA mRNA CTD PMID:17327700 cadmium dichloride multiple interactions ISO RGD:10325 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA more ... CTD PMID:23921151 , PMID:29939372 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CEBPA mRNA CTD PMID:12160620 caffeine decreases expression ISO RGD:2326 6480464 Caffeine results in decreased expression of CEBPA mRNA CTD PMID:23727198 caffeine increases expression ISO RGD:2326 6480464 Caffeine results in increased expression of CEBPA mRNA CTD PMID:30423288 , PMID:30776459 caffeine affects expression ISO RGD:2326 6480464 Caffeine affects the expression of CEBPA mRNA CTD PMID:30528684 calcitriol decreases expression ISO RGD:10325 6480464 Calcitriol results in decreased expression of CEBPA mRNA CTD PMID:16368784 calcium dichloride increases activity EXP 6480464 Calcium Chloride results in increased activity of CEBPA protein CTD PMID:17214633 capsaicin multiple interactions ISO RGD:2326 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] CTD PMID:20359164 capsaicin decreases expression ISO RGD:10325 6480464 Capsaicin results in decreased expression of CEBPA protein CTD PMID:17295509 carbaryl decreases expression EXP 6480464 Carbaryl results in decreased expression of CEBPA mRNA CTD PMID:27829164 carbon nanotube decreases expression ISO RGD:10325 6480464 Nanotubes more ... CTD PMID:25620056 celastrol affects expression ISO RGD:10325 6480464 tripterine affects the expression of CEBPA mRNA, tripterine affects the expression of CEBPA protein CTD PMID:27085773 celecoxib multiple interactions ISO RGD:2326 6480464 Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] CTD PMID:19247274 cerulenin decreases expression ISO RGD:10325 6480464 Cerulenin results in decreased expression of CEBPA mRNA CTD PMID:15707987 ceruletide increases expression ISO RGD:2326 6480464 Ceruletide results in increased expression of CEBPA mRNA CTD PMID:26873426 ceruletide multiple interactions ISO RGD:2326 6480464 [Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPA protein more ... CTD PMID:26873426 chlorpyrifos multiple interactions ISO RGD:10325 6480464 Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA], Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein] CTD PMID:32017950 cholesterol multiple interactions EXP 6480464 [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol CTD PMID:23063590 choline multiple interactions ISO RGD:10325 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... CTD PMID:20938992 , PMID:25712622 choline multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA], [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA CTD PMID:25712622 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CEBPA mRNA CTD PMID:27392435 clofazimine increases expression ISO RGD:2326 6480464 Clofazimine results in increased expression of CEBPA protein CTD PMID:31393584 Clofop multiple interactions EXP 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of CEBPA mRNA CTD PMID:16197558 clozapine multiple interactions ISO RGD:10325 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA], Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA protein] CTD PMID:20564506 clozapine increases expression ISO RGD:10325 6480464 Clozapine results in increased expression of CEBPA mRNA, Clozapine results in increased expression of CEBPA protein CTD PMID:20564506 cobalt dichloride decreases expression ISO RGD:10325 6480464 cobaltous chloride results in decreased expression of CEBPA mRNA CTD PMID:20594416 colforsin daropate hydrochloride multiple interactions ISO RGD:2326 6480464 Colforsin inhibits the reaction [mono-2-ethylhexylphthalate results in decreased expression of CEBPA protein] CTD PMID:21832167 colforsin daropate hydrochloride increases expression ISO RGD:2326 6480464 Colforsin results in increased expression of CEBPA protein CTD PMID:21832167 colforsin daropate hydrochloride multiple interactions ISO RGD:10325 6480464 Colforsin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA] CTD PMID:17407152 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of CEBPA mRNA CTD PMID:19549813 corticosterone increases expression ISO RGD:2326 6480464 Corticosterone results in increased expression of CEBPA mRNA CTD PMID:30423288 cortisol multiple interactions EXP 6480464 CEBPA protein affects the reaction [Hydrocortisone results in increased expression of FASN mRNA] more ... CTD PMID:30528684 , PMID:30776459 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of CEBPA mRNA, Hydrocortisone results in increased expression of CEBPA protein CTD PMID:30528684 more ... cucurbitacin B decreases expression ISO RGD:10325 6480464 cucurbitacin B results in decreased expression of CEBPA mRNA CTD PMID:24316209 cucurbitacin B multiple interactions ISO RGD:10325 6480464 STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of CEBPA mRNA] CTD PMID:24316209 cucurbitacin I decreases expression ISO RGD:10325 6480464 cucurbitacin I results in decreased expression of CEBPA mRNA CTD PMID:24316209 curcumin multiple interactions ISO RGD:10325 6480464 Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] more ... CTD PMID:19297423 , PMID:28595985 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CEBPA mRNA CTD PMID:20106945 more ... D-glucose multiple interactions EXP 6480464 CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 DDE decreases activity EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased activity of CEBPA protein CTD PMID:27589886 DDT multiple interactions ISO RGD:10325 6480464 DDT results in increased activity of and results in increased localization of CEBPA protein CTD PMID:11911853 decabromodiphenyl ether increases expression ISO RGD:2326 6480464 decabromobiphenyl ether results in increased expression of CEBPA mRNA CTD PMID:23914054 Deguelin decreases expression EXP 6480464 [deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CEBPA protein CTD PMID:25242579 deoxynivalenol decreases expression EXP 6480464 deoxynivalenol results in decreased expression of CEBPA mRNA CTD PMID:28935499 deoxynivalenol multiple interactions EXP 6480464 [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CEBPA mRNA CTD PMID:28865950 dexamethasone multiple interactions ISO RGD:10325 6480464 +-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... CTD PMID:11101056 more ... dexamethasone increases expression ISO RGD:10325 6480464 Dexamethasone results in increased expression of CEBPA mRNA CTD PMID:22956630 , PMID:25068083 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CEBPA mRNA CTD PMID:24418828 , PMID:27003841 dexamethasone multiple interactions ISO RGD:2326 6480464 [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] CTD PMID:32494933 dexamethasone multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA more ... CTD PMID:23152186 more ... dexamethasone increases expression ISO RGD:2326 6480464 Dexamethasone results in increased expression of CEBPA mRNA, Dexamethasone results in increased expression of CEBPA protein CTD PMID:12837037 more ... diallyl trisulfide decreases expression ISO RGD:10325 6480464 diallyl trisulfide results in decreased expression of CEBPA mRNA, diallyl trisulfide results in decreased expression of CEBPA protein CTD PMID:22137902 diallyl trisulfide multiple interactions ISO RGD:10325 6480464 [diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in decreased expression of FASN more ... CTD PMID:22137902 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CEBPA mRNA CTD PMID:20458559 diarsenic trioxide decreases expression ISO RGD:10325 6480464 Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:15916724 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CEBPA mRNA, Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:19662097 , PMID:21257625 dibutyl phthalate decreases expression ISO RGD:10325 6480464 Dibutyl Phthalate results in decreased expression of CEBPA mRNA CTD PMID:17361019 , PMID:21266533 dibutylstannane increases expression EXP 6480464 di-n-butyltin results in increased expression of CEBPA mRNA CTD PMID:29787037 dibutylstannane multiple interactions EXP 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of CEBPA mRNA] CTD PMID:29787037 diethylstilbestrol increases expression ISO RGD:10325 6480464 Diethylstilbestrol results in increased expression of CEBPA mRNA, Diethylstilbestrol results in increased expression of CEBPA protein CTD PMID:22710028 diethylstilbestrol multiple interactions ISO RGD:10325 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of CEBPA protein] CTD PMID:22710028 dioxygen decreases expression ISO RGD:10325 6480464 Oxygen deficiency results in decreased expression of CEBPA mRNA CTD PMID:20594416 dioxygen multiple interactions ISO RGD:10325 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPA mRNA CTD PMID:30529165 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CEBPA protein CTD PMID:19662097 duvoglustat multiple interactions ISO RGD:10325 6480464 1-Deoxynojirimycin inhibits the reaction [Dietary Fats results in increased expression of CEBPA mRNA] CTD PMID:25445511 efavirenz decreases expression EXP 6480464 efavirenz results in decreased expression of CEBPA mRNA CTD PMID:21619898 elemental selenium increases expression ISO RGD:10325 6480464 Selenium results in increased expression of CEBPA mRNA CTD PMID:28810182 endosulfan increases expression ISO RGD:2326 6480464 Endosulfan results in increased expression of CEBPA mRNA CTD PMID:29391264 endrin decreases activity ISO RGD:10325 6480464 Endrin results in decreased activity of CEBPA protein CTD PMID:10385688 endrin decreases expression ISO RGD:10325 6480464 Endrin results in decreased expression of CEBPA protein CTD PMID:10385688 epoxomicin multiple interactions EXP 6480464 epoxomicin inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] CTD PMID:19662097 ethanol decreases activity ISO RGD:10325 6480464 Ethanol results in decreased activity of CEBPA protein CTD PMID:16737972 ethanol affects expression ISO RGD:10325 6480464 Ethanol affects the expression of CEBPA mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:2326 6480464 Ethanol results in increased expression of CEBPA mRNA CTD PMID:26188107 more ... ethanol affects expression ISO RGD:2326 6480464 Ethanol affects the expression of CEBPA mRNA CTD PMID:31039417 ethanol decreases expression ISO RGD:10325 6480464 Ethanol results in decreased expression of CEBPA protein CTD PMID:16737972 ethanol multiple interactions ISO RGD:10325 6480464 Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein], Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] CTD PMID:16737972 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CEBPA protein CTD PMID:16737972 ethylparaben increases expression ISO RGD:10325 6480464 ethyl-p-hydroxybenzoate results in increased expression of CEBPA mRNA CTD PMID:22956630 etoposide increases degradation EXP 6480464 Etoposide results in increased degradation of CEBPA protein CTD PMID:19662097 etoposide decreases expression EXP 6480464 Etoposide results in decreased expression of CEBPA mRNA, Etoposide results in decreased expression of CEBPA protein CTD PMID:19662097 fipronil multiple interactions ISO RGD:10325 6480464 AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein] CTD PMID:27103584 fipronil increases expression ISO RGD:10325 6480464 fipronil results in increased expression of CEBPA mRNA, fipronil results in increased expression of CEBPA protein CTD PMID:27103584 flavonoids decreases expression ISO RGD:2326 6480464 Flavonoids results in decreased expression of CEBPA mRNA CTD PMID:23238999 folic acid multiple interactions ISO RGD:10325 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... CTD PMID:20938992 , PMID:22206623 genistein decreases expression ISO RGD:10325 6480464 Genistein results in decreased expression of CEBPA mRNA CTD PMID:21048042 genistein increases expression ISO RGD:2326 6480464 Genistein results in increased expression of CEBPA mRNA CTD PMID:24361872 gingerol decreases expression ISO RGD:10325 6480464 gingerol results in decreased expression of CEBPA mRNA, gingerol results in decreased expression of CEBPA protein CTD PMID:26498061 gingerol multiple interactions ISO RGD:10325 6480464 GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA], GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein] CTD PMID:26498061 glucose multiple interactions EXP 6480464 CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 glycerol 2-phosphate multiple interactions ISO RGD:10325 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein CTD PMID:14505802 glycerol 2-phosphate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA CTD PMID:25932594 GW 501516 multiple interactions EXP 6480464 [GW 501516 binds to PPARD protein] which results in increased expression of CEBPA mRNA CTD PMID:16197558 hemin increases expression ISO RGD:10325 6480464 Hemin results in increased expression of CEBPA mRNA CTD PMID:29749404 hemin multiple interactions ISO RGD:10325 6480464 HAMP mRNA promotes the reaction [Hemin results in increased expression of CEBPA mRNA] CTD PMID:29749404 herbimycin multiple interactions ISO RGD:2326 6480464 herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] CTD PMID:11133817 hesperetin decreases expression EXP 6480464 hesperetin results in decreased expression of CEBPA protein CTD PMID:25345581 hexadecanoic acid multiple interactions ISO RGD:2326 6480464 [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA mRNA more ... CTD PMID:26873426 hispidulin multiple interactions ISO RGD:10325 6480464 hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA] CTD PMID:30055130 hydrazines decreases expression ISO RGD:10325 6480464 Hydrazines results in decreased expression of CEBPA mRNA CTD PMID:21647536 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of CEBPA mRNA CTD PMID:23410634 hydroxytyrosol decreases expression ISO RGD:10325 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of CEBPA mRNA CTD PMID:21569430 indometacin multiple interactions ISO RGD:10325 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA more ... CTD PMID:22107987 , PMID:30055130 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CEBPA mRNA CTD PMID:28628672 isoliquiritigenin multiple interactions ISO RGD:10325 6480464 isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of CEBPA protein] CTD PMID:27117918 isoniazide decreases expression ISO RGD:10325 6480464 Isoniazid results in decreased expression of CEBPA mRNA, Isoniazid results in decreased expression of CEBPA protein CTD PMID:24128855 ivermectin multiple interactions ISO RGD:10325 6480464 Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein], Rosiglitazone affects the reaction [Ivermectin affects the expression of CEBPA mRNA] CTD PMID:31199990 ivermectin affects expression ISO RGD:10325 6480464 Ivermectin affects the expression of CEBPA mRNA CTD PMID:31199990 L-ascorbic acid multiple interactions ISO RGD:10325 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein CTD PMID:14505802 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA CTD PMID:25932594 L-methionine multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA], [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA CTD PMID:25712622 L-methionine multiple interactions ISO RGD:10325 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... CTD PMID:20938992 , PMID:25712622 lead diacetate increases expression ISO RGD:10325 6480464 lead acetate results in increased expression of CEBPA mRNA CTD PMID:20542052 lead diacetate increases methylation ISO RGD:2326 6480464 lead acetate results in increased methylation of CEBPA gene CTD PMID:29571894 lead diacetate decreases expression ISO RGD:10325 6480464 lead acetate results in decreased expression of CEBPA mRNA CTD PMID:21829687 lead(0) increases expression ISO RGD:10325 6480464 Lead results in increased expression of CEBPA CTD PMID:23086611 lead(2+) increases expression ISO RGD:10325 6480464 Lead results in increased expression of CEBPA CTD PMID:23086611 lipopolysaccharide multiple interactions ISO RGD:10325 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein more ... CTD PMID:22107987 lipopolysaccharide decreases expression ISO RGD:10325 6480464 Lipopolysaccharides results in decreased expression of CEBPA mRNA CTD PMID:26582142 lithium chloride multiple interactions ISO RGD:2326 6480464 [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] CTD PMID:32494933 LY294002 multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA] CTD PMID:25712622 menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of CEBPA mRNA CTD PMID:20044591 , PMID:23410634 mercury dichloride decreases expression ISO RGD:10325 6480464 Mercuric Chloride results in decreased expression of CEBPA mRNA CTD PMID:11267658 mercury dichloride multiple interactions ISO RGD:10325 6480464 Mercuric Chloride results in decreased expression of and results in decreased activity of CEBPA protein CTD PMID:11267658 metformin decreases expression ISO RGD:2326 6480464 Metformin results in decreased expression of CEBPA mRNA CTD PMID:19022234 methimazole increases expression ISO RGD:2326 6480464 Methimazole results in increased expression of CEBPA mRNA CTD PMID:22504374 methoxychlor decreases expression ISO RGD:2326 6480464 Methoxychlor results in decreased expression of CEBPA mRNA CTD PMID:23303685 methylparaben increases expression ISO RGD:10325 6480464 methylparaben results in increased expression of CEBPA mRNA CTD PMID:28527915 mifepristone multiple interactions ISO RGD:10325 6480464 Mifepristone inhibits the reaction [bisphenol A results in increased expression of CEBPA mRNA], Mifepristone inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] CTD PMID:22956630 , PMID:27145005 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of CEBPA mRNA] CTD PMID:30528684 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:10325 6480464 mono-2-ethylhexylphthalate results in decreased expression of CEBPA protein CTD PMID:21832167 mono(2-ethylhexyl) phthalate increases expression ISO RGD:10325 6480464 mono-2-ethylhexylphthalate results in increased expression of CEBPA mRNA CTD PMID:25543134 , PMID:27384973 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:2326 6480464 mono-2-ethylhexylphthalate results in decreased expression of CEBPA protein CTD PMID:21832167 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:2326 6480464 Colforsin inhibits the reaction [mono-2-ethylhexylphthalate results in decreased expression of CEBPA protein] CTD PMID:21832167 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:10325 6480464 N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA] CTD PMID:17407152 N-acetyl-L-cysteine multiple interactions ISO RGD:10325 6480464 Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of CEBPA protein] CTD PMID:27117918 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases ubiquitination EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of CEBPA protein CTD PMID:19662097 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] CTD PMID:19662097 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CEBPA mRNA CTD PMID:21527772 N-nitrosodiethylamine decreases expression ISO RGD:2326 6480464 Diethylnitrosamine results in decreased expression of CEBPA mRNA CTD PMID:19638242 N-Nitrosopyrrolidine decreases expression EXP 6480464 N-Nitrosopyrrolidine results in decreased expression of CEBPA mRNA CTD PMID:32234424 nevirapine increases expression EXP 6480464 Nevirapine results in increased expression of CEBPA mRNA CTD PMID:21619898 nicotine multiple interactions ISO RGD:2326 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein CTD PMID:29617909 nicotine affects expression ISO RGD:2326 6480464 Nicotine affects the expression of CEBPA mRNA CTD PMID:31972234 nicotine increases expression ISO RGD:10325 6480464 Nicotine results in increased expression of CEBPA mRNA CTD PMID:31622651 nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of CEBPA mRNA CTD PMID:19131065 nimesulide multiple interactions ISO RGD:10325 6480464 nimesulide promotes the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein] CTD PMID:22107987 nimesulide multiple interactions ISO RGD:2326 6480464 nimesulide inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] CTD PMID:19247274 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of CEBPA CTD PMID:20590410 osthole increases expression ISO RGD:10325 6480464 osthol results in increased expression of CEBPA mRNA CTD PMID:19682441 p-tert-Amylphenol decreases expression ISO RGD:2326 6480464 4-tert-octylphenol results in decreased expression of CEBPA mRNA CTD PMID:26164745 paracetamol multiple interactions ISO RGD:10325 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of CEBPA mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:10325 6480464 Acetaminophen results in decreased expression of CEBPA mRNA CTD PMID:29246445 perfluorobutanesulfonic acid increases expression ISO RGD:10325 6480464 perfluorobutanesulfonic acid results in increased expression of CEBPA mRNA, perfluorobutanesulfonic acid results in increased expression of CEBPA protein CTD PMID:30031040 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10325 6480464 perfluorooctane sulfonic acid results in increased expression of CEBPA mRNA CTD PMID:26548598 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of CEBPA mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CEBPA mRNA CTD PMID:26548598 perfluorooctanoic acid increases activity EXP 6480464 perfluorooctanoic acid results in increased activity of CEBPA protein CTD PMID:27589886 perfluorooctanoic acid multiple interactions ISO RGD:10325 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA], [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA CTD PMID:29094436 permethrin increases expression ISO RGD:10325 6480464 Permethrin results in increased expression of CEBPA mRNA CTD PMID:24911977 Phenylamil increases expression ISO RGD:10325 6480464 phenylamil results in increased expression of CEBPA mRNA CTD PMID:20519739 phenylephrine decreases expression ISO RGD:2326 6480464 Phenylephrine results in decreased expression of CEBPA mRNA CTD PMID:19443575 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10325 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CEBPA mRNA CTD PMID:23519560 pioglitazone increases expression ISO RGD:10325 6480464 pioglitazone results in increased expression of CEBPA mRNA CTD PMID:28242381 pirinixic acid multiple interactions ISO RGD:10325 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of CEBPA mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO RGD:10325 6480464 pirinixic acid results in decreased expression of CEBPA mRNA CTD PMID:18445702 more ... pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CEBPA mRNA CTD PMID:19710929 platycodin D multiple interactions ISO RGD:10325 6480464 CTNNB1 affects the reaction [platycodin D results in decreased expression of CEBPA protein] CTD PMID:21798269 platycodin D decreases expression ISO RGD:10325 6480464 platycodin D results in decreased expression of CEBPA mRNA, platycodin D results in decreased expression of CEBPA protein CTD PMID:21798269 more ... platycodin D decreases expression EXP 6480464 platycodin D results in decreased expression of CEBPA protein CTD PMID:30599906 pomalidomide increases expression EXP 6480464 pomalidomide results in increased expression of CEBPA mRNA CTD PMID:15292067 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:10325 6480464 Pregnenolone Carbonitrile results in decreased expression of CEBPA mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:10325 6480464 propiconazole results in decreased expression of CEBPA mRNA CTD PMID:21278054 propylparaben increases expression ISO RGD:10325 6480464 propylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 prostaglandin E2 multiple interactions ISO RGD:10325 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein]] CTD PMID:25432964 quercetin multiple interactions ISO RGD:2326 6480464 Quercetin inhibits the reaction [[Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPA protein] more ... CTD PMID:26873426 quercetin multiple interactions ISO RGD:10325 6480464 Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein] more ... CTD PMID:18586010 more ... quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CEBPA mRNA CTD PMID:21632981 raloxifene decreases expression EXP 6480464 Raloxifene Hydrochloride results in decreased expression of CEBPA mRNA CTD PMID:15849065 reactive oxygen species decreases expression EXP 6480464 Reactive Oxygen Species results in decreased expression of CEBPA mRNA CTD PMID:25800948 resveratrol decreases expression ISO RGD:10325 6480464 resveratrol metabolite results in decreased expression of CEBPA mRNA more ... CTD PMID:22935344 more ... rimonabant multiple interactions ISO RGD:10325 6480464 Rimonabant inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] CTD PMID:27659731 risperidone multiple interactions ISO RGD:10325 6480464 Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA mRNA], Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA protein] CTD PMID:20564506 risperidone increases expression ISO RGD:10325 6480464 Risperidone results in increased expression of CEBPA mRNA, Risperidone results in increased expression of CEBPA protein CTD PMID:20564506 ritonavir multiple interactions ISO RGD:10325 6480464 Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein] CTD PMID:11101056 rotenone decreases expression ISO RGD:2326 6480464 Rotenone results in decreased expression of CEBPA mRNA, Rotenone results in decreased expression of CEBPA protein CTD PMID:19693701 rottlerin multiple interactions EXP 6480464 rottlerin inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein], rottlerin inhibits the reaction [NSC606985 results in increased ubiquitination of CEBPA protein] CTD PMID:19662097 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 selenium atom increases expression ISO RGD:10325 6480464 Selenium results in increased expression of CEBPA mRNA CTD PMID:28810182 sildenafil citrate increases expression ISO RGD:10325 6480464 Sildenafil Citrate results in increased expression of CEBPA mRNA, Sildenafil Citrate results in increased expression of CEBPA protein CTD PMID:20471953 silibinin multiple interactions ISO RGD:10325 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] CTD PMID:25559859 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of CEBPA mRNA, Silicon Dioxide results in decreased expression of CEBPA mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of CEBPA mRNA CTD PMID:23806026 silver atom decreases expression EXP 6480464 Silver results in decreased expression of CEBPA mRNA CTD PMID:26014281 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of CEBPA mRNA CTD PMID:26014281 sincalide multiple interactions ISO RGD:2326 6480464 [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA mRNA more ... CTD PMID:26873426 sirolimus decreases expression ISO RGD:10325 6480464 Sirolimus results in decreased expression of CEBPA mRNA CTD PMID:15358118 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA CTD PMID:32525701 sodium arsenite multiple interactions EXP 6480464 sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA] CTD PMID:23152186 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CEBPA mRNA CTD PMID:29301061 , PMID:32844245 sodium arsenite decreases expression ISO RGD:10325 6480464 sodium arsenite results in decreased expression of CEBPA mRNA CTD PMID:19822182 more ... sodium arsenite multiple interactions ISO RGD:10325 6480464 sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of CEBPA mRNA] CTD PMID:11812925 sodium chloride increases expression EXP 6480464 Sodium Chloride results in increased expression of CEBPA mRNA CTD PMID:23634900 sodium dichromate increases expression ISO RGD:10325 6480464 sodium bichromate results in increased expression of CEBPA mRNA CTD PMID:31558096 stavudine decreases expression ISO RGD:10325 6480464 Stavudine results in decreased expression of CEBPA protein CTD PMID:15722030 sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of CEBPA mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO RGD:10325 6480464 Tacrolimus results in increased expression of CEBPA mRNA CTD PMID:29362864 tamoxifen decreases expression ISO RGD:10325 6480464 Tamoxifen results in decreased expression of CEBPA mRNA, Tamoxifen results in decreased expression of CEBPA protein CTD PMID:25123088 Tanshinone I increases expression ISO RGD:10325 6480464 tanshinone results in increased expression of CEBPA protein CTD PMID:18344322 Tanshinone I multiple interactions ISO RGD:10325 6480464 [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPA protein], [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPA protein] CTD PMID:18344322 taurine multiple interactions EXP 6480464 [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA] CTD PMID:29078374 tert-butyl hydroperoxide affects expression EXP 6480464 tert-Butylhydroperoxide affects the expression of CEBPA mRNA CTD PMID:23410634 Tesaglitazar increases expression ISO RGD:2326 6480464 tesaglitazar results in increased expression of CEBPA mRNA CTD PMID:21270424 testosterone decreases expression ISO RGD:10325 6480464 Testosterone results in decreased expression of CEBPA mRNA, Testosterone results in decreased expression of CEBPA protein CTD PMID:12960001 tetrachloromethane multiple interactions ISO RGD:10325 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein]] more ... CTD PMID:20438794 , PMID:25432964 tetrachloromethane decreases expression ISO RGD:2326 6480464 Carbon Tetrachloride results in decreased expression of CEBPA mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:10325 6480464 Carbon Tetrachloride results in decreased expression of CEBPA mRNA, Carbon Tetrachloride results in decreased expression of CEBPA protein CTD PMID:17484886 more ... thioacetamide decreases expression ISO RGD:2326 6480464 Thioacetamide results in decreased expression of CEBPA mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:10325 6480464 titanium dioxide results in increased expression of CEBPA mRNA CTD PMID:23409001 topiramate decreases expression ISO RGD:2326 6480464 topiramate results in decreased expression of CEBPA mRNA CTD PMID:16979414 tributylstannane increases expression ISO RGD:10325 6480464 tributyltin results in increased expression of CEBPA mRNA CTD PMID:25932594 , PMID:29787037 tributylstannane multiple interactions ISO RGD:10325 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of CEBPA mRNA] CTD PMID:29787037 tributylstannane multiple interactions EXP 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of CEBPA mRNA] CTD PMID:29787037 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of CEBPA mRNA CTD PMID:28011154 , PMID:29787037 triclosan decreases expression ISO RGD:10325 6480464 Triclosan results in decreased expression of CEBPA mRNA CTD PMID:15707987 triphenyl phosphate multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of CEBPA mRNA, [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of CEBPA mRNA CTD PMID:28437481 triphenyl phosphate increases expression ISO RGD:10325 6480464 triphenyl phosphate results in increased expression of CEBPA mRNA CTD PMID:28163246 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CEBPA mRNA CTD PMID:28934090 triptonide increases expression ISO RGD:10325 6480464 triptonide results in increased expression of CEBPA mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CEBPA mRNA CTD PMID:19022234 troglitazone multiple interactions ISO RGD:10325 6480464 +-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein] more ... CTD PMID:26117538 troglitazone increases expression ISO RGD:10325 6480464 troglitazone results in increased expression of CEBPA mRNA CTD PMID:12732648 more ... troglitazone multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of CEBPA mRNA, troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased expression of CEBPA mRNA]] CTD PMID:27003841 , PMID:7956951 troglitazone decreases expression ISO RGD:2326 6480464 troglitazone results in decreased expression of CEBPA mRNA CTD PMID:19022234 trovafloxacin multiple interactions ISO RGD:10325 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CEBPA mRNA CTD PMID:18930950 urethane decreases expression EXP 6480464 Urethane results in decreased expression of CEBPA mRNA CTD PMID:28818685 valdecoxib decreases expression ISO RGD:2326 6480464 valdecoxib results in decreased expression of CEBPA mRNA CTD PMID:24136188 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of CEBPA gene CTD PMID:29154799 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of CEBPA gene CTD PMID:29501571 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CEBPA mRNA CTD PMID:29154799 , PMID:29501571 valproic acid multiple interactions EXP 6480464 CEBPA protein affects the reaction [Valproic Acid results in decreased expression of CALR mRNA] more ... CTD PMID:32623605 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CEBPA mRNA CTD PMID:19101580 valsartan decreases expression EXP 6480464 Valsartan results in decreased expression of CEBPA mRNA CTD PMID:22768174 vinclozolin decreases expression ISO RGD:2326 6480464 vinclozolin results in decreased expression of CEBPA mRNA CTD PMID:23034163 vitamin E multiple interactions ISO RGD:10325 6480464 Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein], Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] CTD PMID:16737972 zearalenone affects expression EXP 6480464 Zearalenone affects the expression of CEBPA mRNA CTD PMID:28865950 zearalenone multiple interactions EXP 6480464 [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CEBPA mRNA CTD PMID:28865950 zidovudine decreases expression ISO RGD:10325 6480464 Zidovudine results in decreased expression of CEBPA protein CTD PMID:15722030 zinc atom multiple interactions EXP 6480464 CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA], CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] CTD PMID:15389791 , PMID:17363595 zinc atom increases response to substance EXP 6480464 CEBPA protein results in increased susceptibility to Zinc CTD PMID:15389791 zinc(0) multiple interactions EXP 6480464 CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA], CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] CTD PMID:15389791 , PMID:17363595 zinc(0) increases response to substance EXP 6480464 CEBPA protein results in increased susceptibility to Zinc CTD PMID:15389791 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of CEBPA mRNA CTD PMID:20977926